LYMPHANGIOLEIOMYOMATOSIS
Clinical trials for LYMPHANGIOLEIOMYOMATOSIS explained in plain language.
Never miss a new study
Get alerted when new LYMPHANGIOLEIOMYOMATOSIS trials appear
Sign up with your email to follow new studies for LYMPHANGIOLEIOMYOMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a leukemia drug help fight rare lung disease? new trial aims to find out
Disease control Recruiting nowThis study tests the long-term safety of imatinib, a drug already approved for leukemia, in women with lymphangioleiomyomatosis (LAM), a rare cystic lung disease. Twenty women aged 18-64 with LAM will receive either imatinib or a placebo for 6 months. The goal is to see if imatin…
Matched conditions: LYMPHANGIOLEIOMYOMATOSIS
Phase: PHASE1 • Sponsor: Columbia University • Aim: Disease control
Last updated Apr 29, 2026 15:14 UTC
-
Which inhaler works best for rare lung disease? new study aims to find out
Symptom relief Recruiting nowThis study tests whether a nebulizer or a standard inhaler (MDI) delivers albuterol better to improve lung function in women with LAM, a rare progressive lung disease. About 100 women with LAM and breathing problems will stay overnight for 3 days to try each method. The goal is t…
Matched conditions: LYMPHANGIOLEIOMYOMATOSIS
Phase: PHASE1, PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Symptom relief
Last updated May 17, 2026 06:49 UTC
-
New registry tracks pregnancy in rare diseases to boost safety
Knowledge-focused Recruiting nowThis study collects information from pregnant women with Tuberous Sclerosis Complex (TSC) or Lymphangioleiomyomatosis (LAM) and their babies. Researchers will track medication use, side effects, and pregnancy complications to learn how to better manage these conditions during pre…
Matched conditions: LYMPHANGIOLEIOMYOMATOSIS
Sponsor: David M. Ritter • Aim: Knowledge-focused
Last updated May 17, 2026 06:47 UTC
-
Scientists launch major study to unravel mysterious lung disease in women
Knowledge-focused Recruiting nowThis study is for women with lymphangioleiomyomatosis (LAM), a rare lung disease that mainly affects young women. Researchers want to understand how the disease destroys lung tissue at the cellular and genetic level. Up to 2000 participants will help scientists identify the prote…
Matched conditions: LYMPHANGIOLEIOMYOMATOSIS
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC